1(2H)-Phthalazinone, 4-(3-chloro-4-methoxyphenyl)-2-methyl-(158425-61-7)
- Name: 1(2H)-Phthalazinone, 4-(3-chloro-4-methoxyphenyl)-2-methyl-
- Synonyms:
- Molecular Formula:C16H13ClN2O2
- Molecular Weight:300.744
- CAS Registry Number:158425-61-7
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 158425-46-8/1H-2,4-Benzodiazepine, 4,5-dihydro-4-methyl-3-(2-phenylethyl)-1-(4-pyridinyl)-, (E)-2-butenedioate (1:1)
- 158425-47-9/1(2H)-Phthalazinone, 4-(4-chlorophenyl)-2-(2-methoxyethyl)-
- 158425-48-0/1(2H)-Phthalazinone, 2-methyl-4-[4-(1-methylethyl)phenyl]-
- 158425-50-4/1H-2,4-Benzodiazepine, 4,5-dihydro-4-methyl-3-[(4-nitrophenyl)methyl]-1-phenyl-, (E)-2-butenedioate (1:1)
- 158425-51-5/Benzenamine, 4-[(4,5-dihydro-4-methyl-1-phenyl-1H-2,4-benzodiazepin-3-yl)methyl]-, dihydrochloride
- 158425-52-6/Methanesulfonamide, N-[4-[(4,5-dihydro-4-methyl-1-phenyl-1H-2,4-benzodiazepin-3-yl)methyl] phenyl]-
- 158425-53-7/Methanesulfonamide, N-[2-[2-(4,5-dihydro-4-methyl-1-phenyl-1H-2,4-benzodiazepin-3-yl)ethyl] phenyl]-, monohydrochloride
- 158425-54-8/Methanesulfonamide, N-[2-[2-(4,5-dihydro-4-methyl-1-phenyl-1H-2,4-benzodiazepin-3-yl)ethyl] phenyl]-
- 158425-55-9/1H-2,4-Benzodiazepine, 4,5-dihydro-1-(4-methoxyphenyl)-4-methyl-3-[2-(4-nitrophenyl)ethyl]-, monohydrochloride
- 158425-56-0/Benzenamine, 4-[2-[4,5-dihydro-1-(4-methoxyphenyl)-4-methyl-1H-2,4-benzodiazepin- 3-yl]ethyl]-, dihydrochloride
- 158425-59-3/Methanesulfonamide, N-[2-chloro-5-(3,4-dihydro-3-methyl-4-oxo-1-phthalazinyl)phenyl]-
- 158425-60-6/1(2H)-Phthalazinone, 4-(2,4-dichlorophenyl)-2-methyl-
- 158425-61-7/1(2H)-Phthalazinone, 4-(3-chloro-4-methoxyphenyl)-2-methyl-
- 158425-62-8/Benzoic acid, 2-(2,4-diethylbenzoyl)-
- 158425-63-9/1(2H)-Phthalazinone, 4-(2,4-diethylphenyl)-2-methyl-
- 158425-64-0/Phenol, 4-[4,5-dihydro-4-methyl-3-[2-(4-pyridinyl)ethyl]-1H-2,4-benzodiazepin-1- yl]-, dihydrochloride
- 158425-65-1/Phenol, 4-[4,5-dihydro-4-methyl-3-[2-(4-pyridinyl)ethyl]-1H-2,4-benzodiazepin-1- yl]-
- 158425-66-2/Methanesulfonamide, N-[4-[2-[4,5-dihydro-4-methyl-1-[4-[(methylsulfonyl)amino]phenyl]-1H-2, 4-benzodiazepin-3-yl]ethyl]phenyl]-, monohydrochloride
- 158425-67-3/Methanesulfonamide, N-[4-[2-[4,5-dihydro-4-methyl-1-[4-[(methylsulfonyl)amino]phenyl]-1H-2, 4-benzodiazepin-3-yl]ethyl]phenyl]-
- 158425-68-4/1(2H)-Phthalazinone, 8-amino-2-methyl-4-phenyl-, monohydrochloride
- 158425-69-5/Methanesulfonamide, N-(3,4-dihydro-3-methyl-4-oxo-1-phenyl-5-phthalazinyl)-
- 158425-72-0/Acetic acid, (3-methyl-4-nitrophenoxy)-, ethyl ester
- 158425-73-1/Acetic acid, (4-amino-3-methylphenoxy)-, ethyl ester
- 158425-74-2/Acetic acid, (4-amino-2-methoxyphenoxy)-, ethyl ester
- 158425-75-3/Benzenepropanoic acid, (3-methyl-3-oxetanyl)methyl ester
- 158425-76-4/Benzoic acid, 2-(3-chloro-4-methoxybenzoyl)-
- 158425-88-8/Phosphine, [2,4,6-tris(1,1-dimethylethyl)phenyl]-, monopotassium salt
- 15842-76-9/Silane, (2-chlorophenyl)trimethyl-
- 15843-14-8/thallium acetate
- 158431-82-4/Piperidine, 2,2,6,6-tetramethyl-1-selenyl-, lithium salt